Myelodysplastic/ Myeloproliferative Neoplasms Treatment (PDQ®)–Health Professional Version
Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) are treated with chemotherapy or other drugs, stem cell transplant, supportive care, and targeted therapy. They include chronic myelomonocytic leukemia (CMML), juvenile myelomonocytic leukemia (JMML), and atypical chronic myeloid leukemia (aCML). Learn about the clinical features and treatment options for these leukemias.
Media Type: Html
- SourceUrl: https://www.cancer.gov/publishedcontent/syndication/5628.htm
- Syndication ID: 19207
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Monday, March 23, 2020 at 07:11 PM
- Date Syndication Updated: Thursday, May 07, 2020 at 09:11 AM
Tags
General:
myelodysplastic/myeloproliferative neoplasms
Embed Code Snippet
To get the embed code snippet please Login.
